GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (OTCPK:ENZB) » Definitions » Shiller PE Ratio

ENZB (Enzo Biochem) Shiller PE Ratio : (As of Apr. 25, 2025)


View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzo Biochem Shiller PE Ratio Historical Data

The historical data trend for Enzo Biochem's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Shiller PE Ratio Chart

Enzo Biochem Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 204.37 -

Enzo Biochem Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.25 213.81 - - 676.84

Competitive Comparison of Enzo Biochem's Shiller PE Ratio

For the Diagnostics & Research subindustry, Enzo Biochem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Shiller PE Ratio falls into.


;
;

Enzo Biochem Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Enzo Biochem's E10 for the quarter that ended in Jan. 2025 is calculated as:

For example, Enzo Biochem's adjusted earnings per share data for the three months ended in Jan. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jan. 2025 (Change)*Current CPI (Jan. 2025)
=-0.03/134.0288*134.0288
=-0.030

Current CPI (Jan. 2025) = 134.0288.

Enzo Biochem Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201504 -0.060 99.824 -0.081
201507 0.190 100.691 0.253
201510 0.100 100.346 0.134
201601 0.150 99.957 0.201
201604 -0.050 100.947 -0.066
201607 0.770 101.524 1.017
201610 -0.030 101.988 -0.039
201701 -0.020 102.456 -0.026
201704 -0.002 103.167 -0.003
201707 0.002 103.278 0.003
201710 -0.010 104.070 -0.013
201801 -0.020 104.578 -0.026
201804 -0.060 105.708 -0.076
201807 -0.120 106.324 -0.151
201810 -0.130 106.695 -0.163
201901 -0.180 106.200 -0.227
201904 0.470 107.818 0.584
201907 -0.110 108.250 -0.136
201910 -0.160 108.577 -0.198
202001 -0.160 108.841 -0.197
202004 -0.210 108.173 -0.260
202007 -0.070 109.318 -0.086
202010 0.010 109.861 0.012
202101 0.050 110.364 0.061
202104 0.040 112.673 0.048
202107 0.060 115.183 0.070
202110 -0.050 116.696 -0.057
202201 -0.050 118.619 -0.056
202204 -0.100 121.978 -0.110
202207 -0.180 125.002 -0.193
202210 -0.220 125.734 -0.235
202301 -0.230 126.223 -0.244
202304 -0.310 127.992 -0.325
202307 1.170 128.974 1.216
202310 -0.130 129.810 -0.134
202401 -0.060 130.124 -0.062
202404 -0.060 132.289 -0.061
202407 -0.260 132.708 -0.263
202410 -0.070 133.182 -0.070
202501 -0.030 134.029 -0.030

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzo Biochem  (OTCPK:ENZB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Enzo Biochem Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem Business Description

Traded in Other Exchanges
Address
21 Executive Boulevard, Farmingdale, NY, USA, 11735
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
Executives
Steven J Pully director 9800 RICHMOND AVE, SUITE 700, HOUSTON TX 77042
James G. Wolf 10 percent owner 105, FLYWAY DRIVE, KIAWAH ISLAND SC 29455
Hamid Erfanian officer: Chief Executive Officer 527 MADISON AVENUE, NEW YORK NY 10022
Patricia Eckert officer: Interim CFO C/O ENZO BIOCHEM, INC., 81 EXECUTIVE BLVD, SUITE 3, FARMINGDALE NY 11735
Kara Cannon officer: Chief Operating Officer 527 MADISON AVE, NEW YORK NY 10022
Bradley Louis Radoff director 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
David Bench officer: CHIEF FINANCIAL OFFICER ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Harbert Discovery Fund, Lp 10 percent owner HARBERT DISCOVERY FUND GP, LLC, 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Ian B. Walters director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Mary Tagliaferri director 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Clemens Peter J Iv 10 percent owner 2383 N. BERRY'S CHAPEL RD., FRANKLIN TN 37069
Rebecca J. Fischer director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Fabian Blank 10 percent owner, other: See Remarks ROEMERSTRASSE 6, BAD BERTRICH 2M 56864
Harbert Management Corp 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Harbert Discovery Co-investment Fund I Gp, Llc 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203